Cipla Cipla The USFDA has conducted an inspection at the Company’s manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483 Cipla Cipla The USFDA has conducted an inspection at the Company’s manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483

Cipla

Cipla The USFDA has conducted an inspection at the Company's manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483 Cipla

Cipla The USFDA has conducted an inspection at the Company’s manufacturing facility in Goa, India from 10th 21st June 2024. On conclusion of the inspection, the Company received 6 inspectional observations in Form 483

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

Please follow and like us:
Pin Share

By earn

INTRADAY BUY PIND FOR 2 SEPTEMBER Stocks With Major Volume and News MUTUAL FUND SIP MONEY TRIPPLE IN 10 YEARS FII DATA 18 SEPTEMBER MIDCAP AND SMALL CAP SHARES SELL